BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aimo A, Januzzi JL Jr, Vergaro G, Ripoli A, Latini R, Masson S, Magnoli M, Anand IS, Cohn JN, Tavazzi L, Tognoni G, Gravning J, Ueland T, Nymo SH, Rocca HB, Bayes-Genis A, Lupón J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Wilson Tang WH, Grodin JL, Passino C, Emdin M. High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure. Int J Cardiol 2019;277:166-72. [PMID: 30416028 DOI: 10.1016/j.ijcard.2018.10.079] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Aimo A, Vergaro G, Passino C, Clerico A. Evaluation of pathophysiological relationships between renin-angiotensin and ACE-ACE2 systems in cardiovascular disorders: from theory to routine clinical practice in patients with heart failure. Crit Rev Clin Lab Sci 2021;:1-16. [PMID: 34196254 DOI: 10.1080/10408363.2021.1942782] [Reference Citation Analysis]
2 Aimo A. Longitudinal changes in cardiac biomarkers and outcome in heart failure: Sex-related differences. Int J Cardiol 2021;336:84-5. [PMID: 34019970 DOI: 10.1016/j.ijcard.2021.05.027] [Reference Citation Analysis]
3 Aimo A, Castiglione V, Borrelli C, Saccaro LF, Franzini M, Masi S, Emdin M, Giannoni A. Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies. Eur J Prev Cardiolog 2020;27:494-510. [DOI: 10.1177/2047487319870344] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
4 Borovac JA, Glavas D, Susilovic Grabovac Z, Supe Domic D, D'Amario D, Bozic J. Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study. J Clin Med. 2019;8. [PMID: 31366074 DOI: 10.3390/jcm8081132] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
5 Sattar N, Januzzi JL. Can biomarkers help find the 'sweet spot' for treating patients with diabetes? Eur J Heart Fail 2021;23:1037-9. [PMID: 33786946 DOI: 10.1002/ejhf.2175] [Reference Citation Analysis]
6 Rider I, Sorensen M, Brady WJ, Gottlieb M, Benson S, Koyfman A, Long B. Disposition of acute decompensated heart failure from the emergency department: An evidence-based review. Am J Emerg Med 2021;50:459-65. [PMID: 34500232 DOI: 10.1016/j.ajem.2021.08.070] [Reference Citation Analysis]
7 Liu C, Cao Y, He X, Zhang C, Liu J, Zhang L, Wu D, Zhuang X, Xue R, Huang H, Jiang J, Dong B, Sun Y, Dong Y, Zhao J. Association of Cyr61-cysteine-rich protein 61 and short-term mortality in patients with acute heart failure and coronary heart disease. Biomark Med 2019;13:1589-97. [PMID: 31660756 DOI: 10.2217/bmm-2019-0111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Wang CH, Han S, Tong F, Li Y, Li ZC, Sun ZJ. Risk prediction model of in-hospital mortality in heart failure with preserved ejection fraction and mid-range ejection fraction: a retrospective cohort study. Biomark Med 2021;15:1223-32. [PMID: 34498488 DOI: 10.2217/bmm-2021-0025] [Reference Citation Analysis]
9 Castiglione V, Aimo A, Vergaro G, Saccaro L, Passino C, Emdin M. Biomarkers for the diagnosis and management of heart failure. Heart Fail Rev 2021. [PMID: 33852110 DOI: 10.1007/s10741-021-10105-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Yoshihisa A, Takeishi Y. Sleep Disordered Breathing and Cardiovascular Diseases. J Atheroscler Thromb 2019;26:315-27. [PMID: 30814385 DOI: 10.5551/jat.RV17032] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 5.3] [Reference Citation Analysis]
11 Yafasova A, Butt JH, Rørth R. Troponin: an important prognostic biomarker in patients with heart failure and reduced ejection fraction? Eur J Heart Fail 2021. [PMID: 34184381 DOI: 10.1002/ejhf.2282] [Reference Citation Analysis]
12 Tsutamoto T, Sakai H, Yamamoto T, Nakagawa Y. Renal Clearance of N-Terminal pro-Brain Natriuretic Peptide Is Markedly Decreased in Chronic Kidney Disease. Circ Rep 2019;1:326-32. [PMID: 33693158 DOI: 10.1253/circrep.CR-19-0063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
13 Chauin A. The Main Causes and Mechanisms of Increase in Cardiac Troponin Concentrations Other Than Acute Myocardial Infarction (Part 1): Physical Exertion, Inflammatory Heart Disease, Pulmonary Embolism, Renal Failure, Sepsis. Vasc Health Risk Manag 2021;17:601-17. [PMID: 34584417 DOI: 10.2147/VHRM.S327661] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ebong I, Mazimba S, Breathett K. Cardiac Biomarkers in Advanced Heart Failure: How Can They Impact Our Pre-transplant or Pre-LVAD Decision-making. Curr Heart Fail Rep 2019;16:274-84. [PMID: 31741231 DOI: 10.1007/s11897-019-00447-w] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 Al-Khalili F, Kemp-Gudmundsdottir K, Svennberg E, Fredriksson T, Frykman V, Friberg L, Rosenqvist M, Engdahl J. Clinical and echocardiographic characteristics of individuals aged 75/76 years old with screening-detected elevated NT-proBNP levels. Open Heart 2020;7:e001200. [PMID: 32153793 DOI: 10.1136/openhrt-2019-001200] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]